Editorial: LED Phototherapy Blankets—Bridging the Neonatal Jaundice Care Gap with Family-Centered Innovation Tubagus Ferdi Fadilah Department of Pediatri, Faculty of Medicine, Universitas Trisakti Neonatal jaundice is the most common clinical condition affecting newborns worldwide, with 60% of term and 80% of preterm infants developing jaundice in the first week of life.(1,2) For over 50 years, conventional phototherapy has been the gold standard for preventing kernicterus—a form of permanent brain damage from severe hyperbilirubinemia.(3, 4) However, from a public health perspective, its care model presents significant challenges. The reliance on hospital facilities, high costs, and the separation of mother and infant create access gaps and psychosocial impacts that can no longer be overlooked, especially in developing nations like Indonesia.(5) Traditional phototherapy methodologies, characterized by substantial, immobile illumination apparatus, inherently engender a treatment paradigm oriented around technological infrastructure rather than patient-centered care. Neonates undergoing such therapy are necessarily confined within incubation units, frequently resulting in maternal-infant separation during the critical initial postpartum period. The ramifications of this separation transcend mere logistical inconvenience; such practices significantly disrupt the essential maternal-neonatal attachment process, impede the establishment of successful lactation, and precipitate elevated levels of parental psychological distress.(1) From a healthcare systems perspective, this treatment modality imposes considerable burden upon tertiary care facilities and generates pronounced disparities in therapeutic access, whereby geographical location and socioeconomic status become determinative factors in the availability of potentially lifepreserving medical intervention. Technological innovation in the form of Light Emitting Diode (LED) phototherapy blankets offers more than just a technical upgrade; it offers a paradigm shift.(6) By integrating an effective blue-green light source into a flexible, portable blanket, therapy can be administered while the infant remains in its mother's arms.(7) This fundamental change transforms the care model into one that is family-centered—a practice globally recognized as a best practice in neonatal care. The public health advantages of phototherapy blankets are compelling: 1. Decentralized Care and Equitable Access: Their portability and lower operational cost allow these devices to be deployed in primary healthcare settings, such as community health centers (Puskesmas) in remote areas. This drastically reduces the time-totreatment, curtails unnecessary hospital referrals, and provides equitable access for rural infants who previously faced higher risks. Local innovations like the BLUI (Blue Light Universitas Indonesia) Blanket, which has undergone advanced development to ensure it meets thermal safety standards,(8) amplify this potential. 2. Supporting Mother-Infant Bonding and Breastfeeding: By enabling skin-to-skin contact and direct breastfeeding without interrupting treatment, phototherapy blankets actively support the foundations of long-term infant health. Effective breastfeeding is not only crucial for nutrition but also helps reduce bilirubin levels by promoting gut motility. 3. Health System Efficiency: In many countries, phototherapy blankets have paved the way for home-based phototherapy programs for uncomplicated cases. This model has been proven to significantly reduce inpatient costs, lower the risk of nosocomial infections, and free up hospital capacity for critically ill neonates. The successful implementation of this technology necessitates standardization of devices and establishment of comprehensive clinical guidelines. Evidence from existing clinical research substantiates the efficacy of these devices. A preliminary clinical investigation regarding the BLUI Blanket demonstrated significant reduction in bilirubin levels among patients with neonatal jaundice, thereby validating its application as a viable therapeutic intervention.(9) This evidence, in conjunction with technical advancements in thermal regulation mechanisms,(8) provides substantial justification for the adoption of this technology as a safe and effective first-line therapeutic modality. In conclusion, the LED phototherapy blanket represents not merely an alternative treatment modality, but rather constitutes a transformative innovation in neonatal care.(6) This technology serves as a critical nexus between clinical efficacy and familial integrity, facilitating not only the therapeutic management of hyperbilirubinemia but doing so in a manner that preserves the parent-child bond, enhances parental autonomy in care provision, and systematically addresses disparities in healthcare accessibility for neonates irrespective of geographical constraints. It is imperative that policy architects, healthcare institutions, and technological innovators expedite the integration of this therapeutic approach into standard clinical practice to ensure optimal health outcomes for future generations.